Related Experiment Video
Updated: Nov 9, 2025

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.4K
Treatment of Localized and Locally Advanced, High-Risk Prostate Cancer: A Report From the First Prostate Cancer
Raja Khauli1, Robson Ferrigno2, Gustavo Guimarães2
1Naef K. Basile Cancer Institute, Beirut, Lebanon.
JCO Global Oncology
|April 15, 2021
Summary
This study surveyed experts to create treatment guidelines for high-risk prostate cancer (PCa) in developing countries. The recommendations focus on cost-effective, accessible options for localized and locally advanced PCa.
Area of Science:
- Oncology
- Urology
Background:
- High-risk prostate cancer (PCa) poses unique challenges in developing countries.
- Limited resources necessitate tailored treatment and follow-up strategies.
Purpose of the Study:
- To generate and present survey results on critical issues in treating and following localized and locally advanced, high-risk prostate cancer (PCa).
- To focus specifically on the context of developing countries with limited resources.
Main Methods:
- A panel of 99 prostate cancer (PCa) experts developed over 300 survey questions.
- A larger panel of 99 international multidisciplinary cancer experts voted on 67 questions concerning treatment and follow-up for high-risk PCa in resource-limited settings.
- Consensus was defined as 75% agreement; recommendations prioritized cost-effectiveness and accessibility.
Main Results:
- Survey results and expert opinions were tabulated in real-time.
- Recommendations were based on panelist consensus, not solely on literature review.
- Consideration was given to cost-effectiveness and accessibility of therapies in resource-limited areas.
Conclusions:
- The presented voting results and recommendations can guide physicians managing high-risk prostate cancer (PCa) in resource-limited settings.
- This article serves as a crucial reference point in the absence of defined treatment guidelines for prostate cancer (PCa) in developing countries.
Related Concept Videos
Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K

